B
688338
vs
S
Shanghai Composite
Over the past 12 months, Beijing Succeeder Technology Inc has outperformed Shanghai Composite, delivering a return of +35% compared to the Shanghai Composite's +25% growth.
Stocks Performance
688338 vs Shanghai Composite
Performance Gap
688338 vs Shanghai Composite
Performance By Year
688338 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Beijing Succeeder Technology Inc
Glance View
Beijing Succeeder Technology, Inc. engages in research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company is headquartered in Beijing, Beijing and currently employs 266 full-time employees. The company went IPO on 2020-08-06. The firm provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The firm operates its businesses within the domestic market and to overseas markets.
